AKT1 loss correlates with episomal HPV16 in Vulval intraepithelial neoplasia

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Ekeowa Anderson, Arucha L ^a,b   Purdie, Karin J ^a   Gibbon, Karen ^a,b   Byrne, Carolyn R ^a   Arbeit, Jeffrey M ^c   Harwood, Catherine A ^a   O'Shaughnessy, Ryan F L ^a,d  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE;

ARTICLE; COPY NUMBER VARIATION; DOWN REGULATION; EPIDERMIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; TUMOR GROWTH; VIRUS REPLICATION; VULVA DISEASE; VULVAL INTRAEPITHELIAL NEOPLASIA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENE DOSAGE; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; UTERINE CERVICAL NEOPLASMS; VULVA; VULVAR NEOPLASMS;

EID: 84862027778     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038608     Document Type: Article

References (30)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, (2004) Classification of papillomaviruses. Virology. 324: 17-27.
2. Stanley MA, Pett MR, Coleman N, (2007) HPV: from infection to cancer. Biochem Soc Trans. 2007 35: 1456-1460.
3. Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J, (2008) Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol. 43: 353-360.
4. Arron ST, Ruby JG, Dybbro E, Ganem D, Derisi JL, (2011) Transcriptome Sequencing Demonstrates that Human Papillomavirus Is Not Active in Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 131: 1745-1753.
5. Jones RW, (2001) Vulval intraepithelial neoplasia: current perspectives. Eur J Gynaecol Oncol. 22: 393-402.
6. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S, (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 124: 1626-1636.
7. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA, (2008) Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 68: 131-156.
8. Scurry J, Hung J, Flowers L, Kneafsay P, Gazdar A, (1999) Ploidy in human papillomavirus positive and negative vulvar squamous cell carcinomas and adjacent skin lesions. Int J Gynecol Cancer. 9: 187-193.
9. Shtilbans V, Maoxin W, Burstein DE, (2008) Current overview of the role of Akt in cancer studies via applied immunohistochemistry. Ann Diag Pathol 12: 153-160.
10. Ganguly N, Parihar SP, (2009) Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis. J Biosci. 34: 113-123.
11. O'Shaughnessy RF, Akgũl B, Storey A, Pfister H, Harwood CA, et al. (2007a) Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. Cancer Res. 67: 8207-8215.
12. Menges CW, Baglia LA, Lapoint R, McCance DJ, (2006) Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 66: 5555-5559.
13. O'Shaughnessy RF, Welti JC, Cooke JC, Avilion AA, Monks B, et al. (2007b) AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. J Biol Chem. 282: 17297-17305.
14. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, et al. (2005) Development of skin tumors in mice transgenic for early genes of human. Cancer Res 65: 1394-1400.
15. Arbeit JM, Münger K, Howley PM, Hanahan D, (1994) Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol. 68: 4358-4368.
16. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, et al. (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37: 2508-2517.
17. Harwood CA, Spink PJ, Surentheran T, Leigh IM, de Villiers EM, et al. (1999) Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol. 37: 3545-3555.
18. de Koning M, Struijk L, Feltkamp M, ter Schegget J, (2005) HPV DNA detection and typing in inapparent cutaneous infections and premalignant lesions. Methods Mol Med 119: 115-127.
19. Weissenborn SJ, Funke AM, Hellmich M, Mallmann P, Fuchs PG, et al. (2003) Oncogenic human papillomavirus DNA loads in human immunodeficiency virus positive-women with high-grade cervical lesions are strongly elevated. J Clin Microbiol. 41: 2763-2767.
20. Middleton K, Peh W, Southern S, Griffin H, Sotlar K, et al. (2003) Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol. 77: 10186-10201.
21. Raj K, Berguerand S, Southern S, Doorbar J, Beard P, (2004) EE4 protein of human papillomavirus type 16 associates with mitochondria. J Virol. 78: 7199-7207.
22. Davy C, McIntosh P, Jackson DJ, Sorathia R, Miell M, et al. (2009) A novel interaction between the human papillomavirus type 16 E2 and E1&E4 proteins leads to stabilisation of E2. Virology 394: 266-275.
23. Knapp AA, McManus PM, Bockstall K, Moroianu J, (2009) Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein. Virology. 383: 60-68.
24. Winder DM, Pett MR, Foster N, Shivji MK, Herdman MT, et al. (2007) An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events J Pathol. 213: 27-34.
25. Peitsaro P, Johansson B, Syrjanen S, (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40: 886-891.
26. Harwood CA, Proby CM, (2002) Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis.15: 101-114.
27. Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, et al. (2000) Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 61: 289-297.
28. Potocnik M, Kocjan BJ, Seme K, Luzar B, Babic DZ, et al. (2006) Beta-papillomaviruses in anogenital hairs plucked from healthy individuals. J Med Virol. 78: 1673-1678.
29. Flores R, Papenfuss M, Klimecki WT, Giuliano AR, (2006) Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer. 118: 1187-1193.
30. Theelen W, Speel EJ, Herfs M, Reijans M, Simons G, et al. (2010) Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay. Am J Pathol. 177: 2022-2033.